DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
Source
bskyDKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesisdoi.orgYou might also wanna read
Examining the reported rise in colorectal cancer among younger adults: A skeptical look at the evidence
The article examines the reported rise in colorectal cancer (CRC) among young people, critically analyzing various proposed explanations inc
dynomight.net·29d ago
Cdh1 stabilizes STING to boost innate immune activation in renal cell carcinoma, study finds
This article presents research by Zhu et al. on the role of the APC/C adaptor protein Cdh1 in stabilizing STING (a key innate immune sensor)
scim.ag·12h ago
Mayo Clinic researchers map molecular structure of PKCβ protein linked to cancer and neurological disorders
After nearly four decades of research, Mayo Clinic scientists have mapped the molecular structures of protein kinase C beta (PKCβ), a protei
mayocl.in·1d ago
Role of SDR42E1 in Vitamin D Absorption and Cancer Pathogenesis: Insights from an In Vitro Model
The article discusses the role of SDR42E1 in modulating vitamin D absorption and its implications for cancer pathogenesis using an in vitro
frontiersin.org·11mo ago
Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one
theguardian.com·24d ago
Data Analysis: The Rising Incidence of Colorectal Cancer in Younger Adults
This interactive data journalism piece examines the concerning rise of colorectal cancer among younger adults, exploring population trends,
Comments
Sign in to join the conversation.
No comments yet. Be the first.